东风股份(601515.SH):拟收购常州华健药用包装材料70%股权
格隆汇 9 月 7日丨东风股份(601515.SH)公布,公司与温州弘峰企业管理合伙企业(有限合伙)、温州隆畅企业管理合伙企业(有限合伙)、温州溢宸企业管理合伙企业(有限合伙)、常州市弘晁创业投资合伙企业(有限合伙)、顾锁娟、陈祥华、顾锁忠及常州市华健药用包装材料有限公司签署《关于收购常州市华健药用包装材料有限公司70%股权之股权转让协议》,以人民币11025万元的价格受让温州弘峰企业管理合伙企业(有限合伙)、温州隆畅企业管理合伙企业(有限合伙)、温州溢宸企业管理合伙企业(有限合伙)持有的常州市华健药用包装材料有限公司合计70%股权。
华健药包主要从事药用SP复合膜、药用包装铝箔、成型冲压复合硬片(包括冷冲压成型铝、热带型泡罩铝)等的研发、生产和销售,于2019年获得中国医药包装协会颁发的“优秀会员奖”。
公司此次拟同时收购华健药包70%股权及重庆首键药用包装材料有限公司(“首键药包”)75%股权,并实现对两家公司的控股,华健药包及首键药包均为原新三板挂牌企业,在行业内具备较强的规模及实力。华健药包主要生产I类药用包装铝箔、药用SP复合膜、成型冲压复合硬片(冷冲压成型铝、热带泡罩铝)材料,首键药包主要从事I类医药用瓶盖研发、生产、销售,主要产品包括口服液、输液瓶用易刺铝盖、铝塑组合盖和撕拉铝盖等产品,两者与千叶药包在产品品类上相互补充,进一步拓展公司医药包装业务的产品类别,并通过千叶药包、华健药包及首键药包在生产、销售及客户资源上的有效协同,有望进一步做强做大公司的医药包装业务板块,提升公司印刷包装产业板块的整体规模及市场竞争力,加快推进“大包装与大消费产业双轮驱动发展”战略的实施。
此次收购完成后,公司将通过产业链协同、资金支持等优势为华健药包及首键药包未来的发展赋能,提升其经营效益,预计将对公司财务状况及经营指标带来积极的影响。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.